Patricia L Allen - Net Worth and Insider Trading
Patricia L Allen Net Worth
The estimated net worth of Patricia L Allen is at least $160,453 dollars as of 2024-06-01. Patricia L Allen is the VP of Finance and Treasurer of Alnylam Pharmaceuticals Inc and owns about 1,070 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $158,820. Patricia L Allen is the CFO of Zafgen Inc and owns about 1,649 shares of Zafgen Inc (ZFGN) stock worth over $1,633. Patricia L Allen is also the Director of Deciphera Pharmaceuticals Inc and owns about 0 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $0. Details can be seen in Patricia L Allen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Patricia L Allen has not made any transactions after 2020-06-05 and currently still holds the listed stock(s).
Transaction Summary of Patricia L Allen
Patricia L Allen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patricia L Allen owns 5 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) , Larimar Therapeutics Inc (LRMR) , and Alnylam Pharmaceuticals Inc (ALNY) among others .
Click here to see the complete history of Patricia L Allen’s form 4 insider trades.
Insider Ownership Summary of Patricia L Allen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DCPH | Deciphera Pharmaceuticals Inc | 2020-06-05 | director |
| LRMR | Larimar Therapeutics Inc | 2016-03-31 | Chief Financial Officer |
| ALNY | Alnylam Pharmaceuticals Inc | 2006-01-01 | VP of Finance and Treasurer |
 | | 2020-12-22 | director |
| | 2020-12-22 | director |
Patricia L Allen Latest Holdings Summary
Patricia L Allen currently owns a total of 3 stocks. Among these stocks, Patricia L Allen owns 1,070 shares of Alnylam Pharmaceuticals Inc (ALNY) as of January 1, 2006, with a value of $158,820 and a weighting of 98.98%. Patricia L Allen owns 1,649 shares of Zafgen Inc (ZFGN) as of July 26, 2016, with a value of $1,633 and a weighting of 1.02%. Patricia L Allen also owns 0 shares of Deciphera Pharmaceuticals Inc (DCPH) as of June 5, 2020, with a value of $0 and a weighting of 0%.
Latest Holdings of Patricia L Allen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2006-01-01 | 1,070 | 148.43 | 158,820 |
| ZFGN | Zafgen Inc | 2016-07-26 | 1,649 | 0.99 | 1,633 |
| DCPH | Deciphera Pharmaceuticals Inc | 2020-06-05 | 0 | 25.54 | 0 |
Holding Weightings of Patricia L Allen
Patricia L Allen Form 4 Trading Tracker
According to the SEC Form 4 filings, Patricia L Allen has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 0 shares on January 1, 2006, which brought Patricia L Allen around $0.
According to the SEC Form 4 filings, Patricia L Allen has made a total of 0 transactions in Zafgen Inc (ZFGN) over the past 5 years. The most-recent trade in Zafgen Inc is the acquisition of 1,333 shares on July 26, 2016, which cost Patricia L Allen around $49,920.
According to the SEC Form 4 filings, Patricia L Allen has made a total of 2 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 12,000 shares on June 5, 2020, which brought Patricia L Allen around $691,440.
Insider Trading History of Patricia L Allen
- 1
Patricia L Allen Trading Performance
GuruFocus tracks the stock performance after each of Patricia L Allen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Patricia L Allen is 9.06%. GuruFocus also compares Patricia L Allen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Patricia L Allen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Patricia L Allen's insider trading performs compared to the benchmark.
Performance of Patricia L Allen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.29 | | | | | |
| Relative Return to S&P 500(%) | -1.28 | | | | | |
Patricia L Allen Ownership Network
Patricia L Allen Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Patricia L Allen is the director of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include SVP & Regulatory & Quality Jama Pitman , Chief Commercial Officer Daniel C. Martin , and Chief Financial Officer Thomas Patrick Kelly .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Patricia L Allen made no insider transaction in Deciphera Pharmaceuticals Inc (DCPH). Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 26,559 shares made by Daniel C. Martin , a net sale of 14,587 shares made by Matthew L Sherman , and a net sale of 11,601 shares made by Thomas Patrick Kelly .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 154,121 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 1,687,666 shares were bought by its insiders, resulting in a net purchase of 1,533,545 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Patricia L Allen Mailing Address
Above is the net worth, insider trading, and ownership report for Patricia L Allen. You might contact Patricia L Allen via mailing address: C/o Deciphera Pharmaceuticals, Inc, 200 Smith Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
